Novartis Bioventures Ltd Yumanity Therapeutics, Inc. (YMTX) insider trading activity

Novartis Bioventures LTD is > 10% Shareholder of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 1.87 Million shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Feb 17, 2016, when has been sold 375,000 shares (Common Stock) at a price of $8.0 per share, resulting in proceeds of $3,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.87M

0% 3M change

0% 12M change

Total Value Held $0

Novartis Bioventures Ltd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 17 2016	BUY Open market or private purchase	$3,000,000 $8.0 p/Share	375,000 Added 16.68%	1,873,791 Common Stock
Feb 17 2016	BUY Conversion of derivative security	-	1,498,791 Added 50.0%	1,498,791 Common Stock

Also insider at

ATRX

Adhera Therapeutics, Inc. Healthcare

> 10% Shareholder

ELDN

Eledon Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

RARX

Ra Pharmaceuticals, Inc.

> 10% Shareholder

AADI

Aadi Bioscience, Inc. Healthcare

> 10% Shareholder

ALRN

AILERON THERAPEUTICS INC Healthcare

> 10% Shareholder

ALT

Altimmune, Inc. Healthcare

> 10% Shareholder

BCYC

BICYCLE THERAPEUTICS plc Healthcare

> 10% Shareholder

GRTX

Galera Therapeutics, Inc. Healthcare

AKUS

Akouos, Inc. Healthcare

NBL